1.Pain Management for Patients with Malignant Psoas Syndrome with Repeated Single-shot Epidural Block for Palliative Radiation Therapy: A Case Report
Palliative Care Research 2017;12(3):547-551
Malignant psoas syndrome (MPS) is caused by malignant infiltration of the psoas muscle and adjacent nerves. Patients with MPS have a combination of pain, both neuropathic and nociceptive, which is often refractory to conventional analgesic therapy. We report the case of a 53-year-old female patient with left MPS caused by the growth of pelvic lymph node metastases from uterine carcinosarcoma. Palliative radiation therapy (RT) to the regional lymph nodes was planned; however, we could not start it because the patient was unable to extend her left hip and stay at rest in the supine position during the RT. We administered epidural analgesia with short-acting local anesthetics 30 min before RT. She could extend her hips despite remaining of pain. We then administered single-shot epidural analgesia just before every RT and were able to perform RT as scheduled. Multimodal approach is needed to manage MPS. In this case, combined oral treatment and epidural analgesia was an effective analgesic therapy for relief of pain due to MPS. Here we report the effective pain management of MPS with repeated single-shot epidural block for palliative RT.
2.Intravenous Corticotropin-releasing Hormone Administration Increases Esophageal Electrical Sensitivity in Healthy Individuals.
Takahisa YAMASAKI ; Toshihiko TOMITA ; Mayu TAKIMOTO ; Takashi KONDO ; Katsuyuki TOZAWA ; Yoshio OHDA ; Tadayuki OSHIMA ; Hirokazu FUKUI ; Jiro WATARI ; Hiroto MIWA
Journal of Neurogastroenterology and Motility 2017;23(4):526-532
BACKGROUND/AIMS: When a person is experiencing stress, corticotropin-releasing hormone (CRH) can modulate gut physiologies, such as visceral sensation or gastrointestinal motility, and its intravenous administration mimics stress-induced physiological changes. However, the influence of CRH on the esophagus is yet unknown. Accordingly, we investigated whether intravenous CRH administration increases esophageal sensitivity to electrical stimulation in healthy Japanese subjects. METHODS: Twenty healthy subjects were recruited. We quantified the initial perception threshold (IPT) every 15 minutes after CRH injection. Venous blood was collected with a cannula, and both plasma adrenocorticotropic hormone (ACTH) and cortisol were measured at pre-stimulation, 0, 30, 60, 90, and 120 minutes. The results from each time point were compared against a baseline IPT obtained before electrical stimulation was initiated. RESULTS: When compared to the baseline IPT value (16.9 ± 4.5), CRH significantly decreased electrical threshold of the esophagus at 30, 45, 60, 75 minutes (14.1 ± 4.2, 13.1 ± 5.0, 12.1 ± 5.7, 14.0 ± 5.8 minutes, P < 0.01, respectively) after CRH injection, suggesting that CRH increased esophageal sensitivity to the electrical stimulus. CRH also significantly increased plasma ACTH levels at 30 minutes (50.3 ± 17.7, P < 0.01), and cortisol levels at 30 minutes (22.0 ± 6.7 minutes, P < 0.01) and 60 minutes (20.3 ± 6.7 minutes, P < 0.01) after CRH injection, when compared to the pre-stimulation ACTH and cortisol values. CONCLUSION: Intravenous CRH administration increased esophageal electrical sensitivity in normal subjects, emphasizing the important role of stress in esophageal sensitivity.
Administration, Intravenous
;
Adrenocorticotropic Hormone
;
Asian Continental Ancestry Group
;
Catheters
;
Corticotropin-Releasing Hormone*
;
Electric Stimulation
;
Esophagus
;
Gastrointestinal Motility
;
Healthy Volunteers
;
Humans
;
Hydrocortisone
;
Plasma
;
Sensation
3.Prevalence of Irritable Bowel Syndrome–like Symptoms in Japanese Patients with Inactive Inflammatory Bowel Disease.
Toshihiko TOMITA ; Yu KATO ; Mayu TAKIMOTO ; Takahisa YAMASAKI ; Takashi KONDO ; Tomoaki KONO ; Katsuyuki TOZAWA ; Yoko YOKOYAMA ; Hisatomo IKEHARA ; Yoshio OHDA ; Tadayuki OSHIMA ; Hirokazu FUKUI ; Shigemi TANAKA ; Masayuki SHIMA ; Jiro WATARI ; Hiroto MIWA
Journal of Neurogastroenterology and Motility 2016;22(4):661-669
BACKGROUND/AIMS: Few studies are available that have investigated the risk factors for overlapping irritable bowel syndrome (IBS)-like symptoms in patients with inactive inflammatory bowel disease (IBD). The present study has 3 objectives: (1) to assess the prevalence of IBS-like symptoms in Japanese patients with inactive IBD using Rome III criteria, (2) to examine the relationship of IBS-like symptoms to health related quality of life (HR-QOL), and (3) to investigate associations for developing IBS-like symptoms in patients with inactive IBD. METHODS: IBS-like symptoms were evaluated using the Rome III questionnaire for functional gastrointestinal disorders. HR-QOL and hospital anxiety and depression scale were evaluated. RESULTS: IBS-like symptoms were found in 17.5% (7/40) of patients with inactive ulcerative colitis, 27.1% (29/107) of patients with inactive Crohn’s disease (CD), and 5.3% (23/438) of healthy control subjects. The QOL level was significantly lower and anxiety score was significantly higher in inactive CD patients with IBS-like symptoms than in those without such symptoms (P = 0.003, P = 0.009). Use of anti-anxiety drugs was associated with the presence of IBS symptoms (P = 0.045). HR-QOL score was lower and anxiety score was higher in patients with inactive ulcerative colitis, but the difference was not statistically significant. CONCLUSIONS: The prevalence of IBS-like symptoms in inactive IBD patients was significantly higher than in healthy controls. Inactive CD patients with IBS-like symptoms has low QOL and anxiety; suggesting that anxiety may be associated with symptom development in such patients.
Anti-Anxiety Agents
;
Anxiety
;
Asian Continental Ancestry Group*
;
Colitis, Ulcerative
;
Depression
;
Gastrointestinal Diseases
;
Humans
;
Inflammatory Bowel Diseases*
;
Irritable Bowel Syndrome
;
Prevalence*
;
Quality of Life
;
Risk Factors